Surgepays Price To Book vs. Current Valuation
| SURG Stock | USD 1.75 0.05 2.78% |
For Surgepays profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Surgepays to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Surgepays utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Surgepays's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Surgepays over time as well as its relative position and ranking within its peers.
Surgepays |
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share (1.18) | Revenue Per Share 6.864 | Quarterly Revenue Growth (0.58) | Return On Assets (0.02) |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Surgepays Current Valuation vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Surgepays's current stock value. Our valuation model uses many indicators to compare Surgepays value to that of its competitors to determine the firm's financial worth. Surgepays is currently regarded as top stock in price to book category among its peers. It also is currently regarded number one company in current valuation category among its peers reporting about 15,082,985 of Current Valuation per Price To Book. Comparative valuation analysis is a catch-all technique that is used if you cannot value Surgepays by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Surgepays Current Valuation vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Surgepays |
| = | 1.06 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Surgepays |
| = | 16.05 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Surgepays Current Valuation vs Competition
Surgepays is currently regarded number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Communication Services industry is at this time estimated at about 14.62 Billion. Surgepays adds roughly 16.05 Million in current valuation claiming only tiny portion of stocks in Communication Services industry.
Surgepays Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Surgepays, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Surgepays will eventually generate negative long term returns. The profitability progress is the general direction of Surgepays' change in net profit over the period of time. It can combine multiple indicators of Surgepays, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 18.9 M | 19.8 M | |
| Income Before Tax | 18.4 M | 19.3 M | |
| Total Other Income Expense Net | -485.8 K | -510.1 K | |
| Net Income | 20.6 M | 21.6 M | |
| Income Tax Expense | -2.3 M | -2.2 M | |
| Net Income From Continuing Ops | 20.6 M | 21.7 M | |
| Net Loss | -612.7 K | -643.3 K | |
| Net Interest Income | -596 K | -625.8 K | |
| Interest Income | 1.3 M | 1.1 M | |
| Non Operating Income Net Other | -518.4 K | -544.3 K | |
| Change To Netincome | -3.3 M | -3.1 M | |
| Net Income Per Share | 1.45 | 1.52 | |
| Income Quality | 0.50 | 0.57 | |
| Net Income Per E B T | 1.12 | 0.80 |
Surgepays Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Surgepays. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Surgepays position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Surgepays' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Surgepays without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Use Investing Themes to Complement your Surgepays position
In addition to having Surgepays in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Pharmaceutical Products Thematic Idea Now
Pharmaceutical Products
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
To fully project Surgepays' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Surgepays at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Surgepays' income statement, its balance sheet, and the statement of cash flows.